Delivery Order SPE2DR25D3004-SPE2DR26FXTT8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,762.83 to AmerisourceBergen Drug Corp for the supply of Vaxelis vaccine syringes (0.5ml) under a firm fixed price contract. The delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of December 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,230.36 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, non-set-aside contract represents a firm fixed-price purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. The contract will...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) with a ceiling value of $7,584.73. The delivery order, issued on December 19, 2025, is scheduled for completion by December 22, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this procurement, supporting the agency's medical supply chain...
- The Defense Logistics Agency awarded a delivery order valued at $1,726.59 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on December 23, 2025, with an ultimate completion date of December 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this transaction. The award represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,124.72 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) on November 7, 2025, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $6,406.74 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5ML) on November 13, 2025, with an ultimate completion date of November 14, 2025. This firm fixed-price contract represents a non-set-aside competitive award for medical supply procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) under a firm fixed-price contract valued at $1,947.21, with an ultimate completion date of June 2, 2025. This competitively awarded, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,394.80 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) with an ultimate completion date of June 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued on June 18, 2025. The contractor's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) valued at $6,394.80 under a firm fixed-price contract. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-set-aside competitively awarded delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, will perform this work...
- The Defense Logistics Agency awarded a delivery order valued at $3,453.18 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on December 23, 2025, with an ultimate completion date of December 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXTT8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,755.24 to Amerisourcebergen Drug Corp for Vaxelis vaccine syringes in 0.5ML configuration, with performance completion expected by January 14, 2026. This is a firm fixed-price, non-set-aside contract performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at up to $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare systems. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor and healthcare solutions provider that supplies a broad portfolio of medications, vaccines, medical devices, and specialized healthcare commodities to federal agencies. The company's extensive experience delivering pharmaceutical products through competitively awarded contracts demonstrates its capability to meet federal medical procurement requirements. This delivery order for vaccine syringes supports the Defense Logistics Agency's mission to supply critical medical commodities to military treatment facilities, veterans' healthcare programs, and other government healthcare institutions worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 1/12/26 |